State Of Wisconsin Investment Board Spero Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $23,384 - $235,104	-31,600 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$13.09 - $18.77 $413,644 - $593,132	31,600 New	31,600 $506,000
Q2 2021 Aug 12, 2021	SELL	$12.22 - $15.79 $252,954 - $326,853	-20,700 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$11.65 - $22.07 $30,290 - $57,382	-2,600 Reduced 11.16%	20,700 $401,000
Q3 2020 Nov 16, 2020	BUY	$8.96 - $14.12 $208,768 - $328,996	23,300 New	23,300 $260,000

Q1 2020 May 06, 2020	SELL	$5.27 - $10.41 $86,955 - $171,765	-16,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.46 - $12.16 $4,134 - $5,313	437 Added 2.72%	16,500 $159,000
Q3 2019 Nov 12, 2019	BUY	$9.01 - $12.55 $41,112 - $57,265	4,563 Added 39.68%	16,063 $170,000
Q2 2019 Aug 14, 2019	BUY	$10.25 - $14.36 $3,075 - $4,308	300 Added 2.68%	11,500 $132,000
Q1 2019 May 13, 2019	BUY	$6.26 - $13.31 $70,112 - $149,072	11,200 New	11,200 $143,000

15.4M

19.6K

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $45.6M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.